|
Market Cap (5-Nov) $68,479,168 (1,490th) |
Close (30-Jun) $0.036 |
Volume (30-Jun) 196,850 |
Shortsold (21-Jul) 1,426 (0.00%) (649th) |
|
52w High $0.300 |
52w Low $0.140 |
P/E - |
EPS -0.02 |
OSX: Commences AI-Powered Design Study for Cranial Implants
SHG released this announcement to the ASX on 14 March 2022, 9:27. The announcement is not marked as price sensitive, and is 3 page(s) in length and 253.05kb in size.
This announcement originated from OSX.
You can view all announcements from SHG and see how they appear on a price chart on the announcements page.
At the date of this announcement, SHG was 0.001% short sold according to ASIC data. It was ranked the 644th most shorted stock on the ASX. It remains ranked 649th as of the latest reported data (21 July 2026).
| Other Recent Announcements from SHG | |
|---|---|
| Auditor Appointment/Resignation | 29 June 2023, 16:28 |
| Update - Notification regarding unquoted securities - SHG | 27 June 2023, 17:10 |
| Change of Director's Interest Notice | 26 June 2023, 18:28 |
| OSX: Commences AI-Powered Design Study for Cranial Implants | 14 March 2022, 9:27 |
| SHG & CSIRO AI Tool to Optimise Cranial Implant Procedures | 14 March 2022, 8:19 |
| Half Year Accounts | 24 February 2022, 19:05 |
| China-based JV Formed and 3Dicom trial at Macau Hospital | 24 February 2022, 10:00 |
If you were already registered, log in here.